Infinite Reality’s SPAC Partner, Newbury Street Acquisition Corp., Announces Nasdaq Extension for Proposed Business Combination
June 12, 2024 16:08 ET
|
Infinite Reality Inc.
NEW YORK, June 12, 2024 (GLOBE NEWSWIRE) -- Infinite Reality (“Infinite Reality” or “iR”), a leading global provider of cutting-edge virtual, AI-powered immersive experiences, today announced that,...
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports First-Quarter Results
June 12, 2024 16:05 ET
|
Oxford Industries, Inc.
Oxford: Owner of Tommy Bahama, Lilly Pulitzer and Johnny Was Reports First-Quarter Results
Ultragenyx Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
June 12, 2024 16:05 ET
|
Ultragenyx Pharmaceutical Inc.
NOVATO, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for...
Dave & Buster’s Reports First Quarter 2024 Financial Results, Repurchases $50 Million of Shares and Executes Sale Leaseback Agreement of Two Properties for $45 Million
June 12, 2024 16:05 ET
|
Dave & Buster's Entertainment, Inc.
DALLAS, June 12, 2024 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ: PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues,...
Pliant Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
June 12, 2024 16:05 ET
|
Pliant Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on June 10, 2024, it granted stock options to purchase an aggregate of...
Array CEO Kevin Hostetler Testifies Before Congress on the Solar Manufacturing Boom from the Inflation Reduction Act
June 12, 2024 16:01 ET
|
Array Technologies, Inc.
Appearing before the Joint Economic Committee, Hostetler highlighted how the IRA has helped Array create American manufacturing jobs
Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares and Concurrent Private Placement
June 12, 2024 16:01 ET
|
Rapport Therapeutics, Inc.
BOSTON and SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational...
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
June 12, 2024 16:01 ET
|
Barinthus Biotherapeutics
Barinthus Bio Announces Strategic Pipeline Prioritization Following Positive Interim Data from VTP-300 in Chronic Hepatitis B Virus Infections
Cara Therapeutics Announces Outcome of Part A of KOURAGE-1 Study Evaluating Oral Difelikefalin in Notalgia Paresthetica
June 12, 2024 16:01 ET
|
Cara Therapeutics, Inc.
– Oral difelikefalin did not demonstrate meaningful clinical benefit compared to placebo – – Company will discontinue clinical program in NP and explore strategic alternatives – STAMFORD, Conn.,...
Clearday Supports National Health Observances
June 12, 2024 16:00 ET
|
Clearday, Inc.
San Antonio, TX, June 12, 2024 (GLOBE NEWSWIRE) -- Clearday (OTC- CLRD), supports the post on May 29, 2024, from the Office of Disease Prevention and Health Promotion. Said office features monthly...